Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 16257339

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer).

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2005 Oct 29-Nov 4
First author
Thatcher N

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2005 Oct 29-Nov 4;366(9496):1507-8. doi: 10.1016/S0140-6736(05)67608-8.
    note
    Source null
    related pmid
    16257327
    relationship
    Comment in
  2. citation
    Lancet. 2006 Jan 28;367(9507):299-300. doi: 10.1016/S0140-6736(06)68063-X.
    note
    Source null
    related pmid
    16443032
    relationship
    Comment in
  3. citation
    Lancet. 2006 Jan 28;367(9507):300. doi: 10.1016/S0140-6736(06)68064-1.
    note
    Source null
    related pmid
    16443034
    relationship
    Comment in

Authors and identifiers

  1. name
    Thatcher N
    type
    Author
  2. name
    Chang A
    type
    Author
  3. name
    Parikh P
    type
    Author
  4. name
    Rodrigues Pereira J
    type
    Author
  5. name
    Ciuleanu T
    type
    Author
  6. name
    von Pawel J
    type
    Author
  7. name
    Thongprasert S
    type
    Author
  8. name
    Tan EH
    type
    Author
  9. name
    Pemberton K
    type
    Author
  10. name
    Archer V
    type
    Author
  11. name
    Carroll K
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Thatcher N
    type
    Author
  2. name
    Chang A
    type
    Author
  3. name
    Parikh P
    type
    Author
  4. name
    Rodrigues Pereira J
    type
    Author
  5. name
    Ciuleanu T
    type
    Author
  6. name
    von Pawel J
    type
    Author
  7. name
    Thongprasert S
    type
    Author
  8. name
    Tan EH
    type
    Author
  9. name
    Pemberton K
    type
    Author
  10. name
    Archer V
    type
    Author
  11. name
    Carroll K
    type
    Author
bibliography ids
  1. nci-bib-d8aee402284aeb8c4c27671d
book metadata
content sha256
ebb0034e852d002cb11c1df118d1181eaac73c232fbd93e27e1dca282b2e1cb0
document type
citation
dois
  1. 10.1016/S0140-6736(05)67625-8
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:16257339
immutable id
pubmed:16257339@ebb0034e852d002cb11c1df118d1181eaac73c232fbd93e27e1dca282b2e1cb0
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9496
name
Lancet (London, England)
nlm unique id
2985213R
pages
1527-37
volume
366
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2005 Oct 29-Nov 4;366(9496):1507-8. doi: 10.1016/S0140-6736(05)67608-8.
    note
    Source null
    related pmid
    16257327
    relationship
    Comment in
  2. citation
    Lancet. 2006 Jan 28;367(9507):299-300. doi: 10.1016/S0140-6736(06)68063-X.
    note
    Source null
    related pmid
    16443032
    relationship
    Comment in
  3. citation
    Lancet. 2006 Jan 28;367(9507):300. doi: 10.1016/S0140-6736(06)68064-1.
    note
    Source null
    related pmid
    16443034
    relationship
    Comment in
outcomes validated
false
pmid
16257339
provenance
batch id
a181c30258a88d182e78
provider
NCBI PubMed ESummary
record sha256
0ff3c7ee50413d33cdacca9c1ae5d65dad3bf91c90219669a518448c7d01cbf4
response sha256
558e0dce453ae424567844b062522ebd1d27363c3312c81dbf6f32a8ff08da24
retrieved at
2026-09-09T23:46:03.896343+00:00
publication date
display
2005 Oct 29-Nov 4
precision
range_or_season
year
2005
publication types
  1. Clinical Trial
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/16257339/
title
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer).

Preserved source evidence · Not medical advice